The Beta Thalassemia-HBB Deletion/Duplication Analysis Test is a specialized genetic screening designed to identify deletions or duplications in the HBB gene, which are associated with beta thalassemia, a blood disorder that reduces the production of hemoglobin. Hemoglobin is essential for oxygen transport in the blood, and its deficiency leads to anemia and other related health issues. This test is crucial for individuals with a family history of beta thalassemia or those showing symptoms of the disorder, as it can provide definitive genetic evidence of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The process involves collecting a blood sample from the patient, which is then analyzed using advanced genetic testing techniques to detect any genetic abnormalities in the HBB gene.
The cost of the Beta Thalassemia-HBB Deletion/Duplication Analysis Test at DNA Labs UAE is 2100 AED. This investment in health can be invaluable for affected families, offering insights into genetic conditions, guiding treatment options, and helping in family planning decisions.
A muscle biopsy with special stains and immunohistochemistry (IHC) tests is a diagnostic procedure used to examine muscle tissue in detail. This test is crucial for diagnosing various muscle disorders, including muscular dystrophies, inflammatory myopathies, and metabolic muscle diseases. During the procedure, a small sample of muscle tissue is removed, typically under local anesthesia. The sample is then subjected to special staining techniques and IHC testing. Special stains can highlight different components of the muscle tissue, revealing abnormalities in muscle fibers, connective tissue, and blood vessels. Immunohistochemistry further enhances the diagnostic capability by using antibodies to detect specific proteins within the muscle tissue, helping to identify the presence and distribution of certain diseases.
At DNA Labs UAE, this comprehensive test is offered for 2100 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results. DNA Labs UAE provides a comfortable and safe environment for patients undergoing this test, ensuring that the procedure is conducted with the utmost care and precision.
The CAH Deletion and Duplication Detection Test is a specialized genetic analysis offered by DNA Labs UAE, designed to identify deletions and duplications in the genes associated with Congenital Adrenal Hyperplasia (CAH). CAH is a group of inherited genetic conditions that affect the adrenal glands, leading to a variety of symptoms ranging from mild to severe. These genetic anomalies can disrupt the normal production of hormones such as cortisol and aldosterone, which are crucial for maintaining various bodily functions.
The test is particularly valuable for individuals who have a family history of CAH or exhibit symptoms related to the condition, as it can provide definitive genetic evidence of the presence or absence of deletions and duplications that cause CAH. Early detection and diagnosis are critical for managing the condition effectively and reducing the risk of potential complications.
DNA Labs UAE offers this comprehensive test at a cost of 2100 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic testing techniques. The results of the test can guide healthcare providers in making informed decisions about treatment and management strategies for individuals diagnosed with CAH, as well as offer valuable information for family planning.
In summary, the CAH Deletion and Duplication Detection Test provided by DNA Labs UAE is a crucial tool for the early detection and management of Congenital Adrenal Hyperplasia, offering individuals and families peace of mind through precise genetic insights at a cost of 2100 AED.
The CLL Panel Deletion/Duplication Detection Test is a specialized genetic test offered by DNA Labs UAE, designed to identify chromosomal deletions and duplications associated with Chronic Lymphocytic Leukemia (CLL). CLL is a type of cancer that affects the blood and bone marrow, and the presence of specific genetic abnormalities can influence both the prognosis and treatment strategies for individuals diagnosed with this condition. This test analyzes multiple genes known to be relevant in CLL to detect any genetic alterations that might be present.
The cost of the CLL Panel Deletion/Duplication Detection Test at DNA Labs UAE is 2100 AED. This comprehensive test is conducted in a state-of-the-art facility, ensuring accurate and reliable results. By identifying genetic mutations, healthcare providers can tailor treatment plans more effectively to the needs of each patient, potentially improving outcomes. This test is an invaluable tool for both the diagnosis and management of Chronic Lymphocytic Leukemia, offering insights that could lead to more personalized and effective treatment approaches.
The CXCR4 Gene Mutation Analysis Test is a specialized genetic assessment conducted at DNA Labs UAE, designed to identify mutations in the CXCR4 gene. This gene plays a crucial role in the immune system by directing the movement of immune cells to areas of the body where they are needed. Mutations in the CXCR4 gene can lead to various health issues, including immune system dysfunctions and certain types of cancer. The test is pivotal for individuals with suspected genetic abnormalities affecting the CXCR4 gene, offering insights that can guide treatment and management decisions. Priced at 2100 AED, this comprehensive analysis is an essential tool for healthcare professionals and patients aiming to understand the genetic underpinnings of specific medical conditions related to the CXCR4 gene.
Cystic Fibrosis (CF) is a genetic disorder that affects the respiratory and digestive systems, leading to severe complications over time. The condition is caused by mutations in the CFTR gene, with the deletion of phenylalanine at position 508 (delF508) being the most common mutation responsible for CF. Early detection of this mutation can significantly impact the management and prognosis of the disease.
The Cystic Fibrosis Mutation Screening CFTR - Del 508 Prenatal Test is a specialized diagnostic procedure aimed at detecting the presence of the delF508 mutation in the fetus during pregnancy. This test is crucial for expectant parents with a family history of Cystic Fibrosis or those identified as carriers of CF mutations, as it helps in making informed decisions regarding the health of their unborn child.
Performed at DNA Labs UAE, a leading facility in genetic testing, this prenatal test offers a reliable means of identifying the delF508 mutation. The test cost is set at 2100 AED, reflecting the comprehensive analysis and expertise involved in delivering accurate results. By opting for this prenatal screening, parents can gain early insights into their child's genetic health, paving the way for prompt interventions and support if needed.
The "DMD Carrier Screening 79 Exons Test" is a specialized genetic test designed to identify carriers of Duchenne Muscular Dystrophy (DMD), a severe type of muscular dystrophy that primarily affects boys. This comprehensive screening targets all 79 exons of the DMD gene, which is responsible for the production of dystrophin, a protein crucial for muscle function. A mutation or error in any of these exons can lead to DMD or Becker Muscular Dystrophy, a milder form of the disease.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is crucial for individuals with a family history of DMD, offering them valuable insights into their carrier status. Knowing one's carrier status can aid in family planning decisions and allow for early intervention strategies if a child is born with the condition. The test is priced at 2100 AED, reflecting the comprehensive nature of the screening and the sophisticated technology employed to ensure accurate results.
The T4 Antibody Test is a specialized diagnostic procedure aimed at detecting the presence of antibodies against Thyroxine (T4) in the bloodstream. Thyroxine is a crucial hormone produced by the thyroid gland, playing a vital role in regulating metabolism, energy generation, and overall growth and development. The presence of T4 antibodies can indicate autoimmune conditions affecting the thyroid, such as Graves' disease or Hashimoto's thyroiditis, where the immune system mistakenly targets the thyroid gland.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic solutions and expert medical staff, the T4 Antibody Test is executed with precision and care. For those seeking to undergo this test, it is priced at 2800 AED. The cost reflects the sophisticated nature of the assay and the comprehensive analysis provided, ensuring accurate and reliable results. Patients considering this test can expect a seamless and supportive experience at DNA Labs UAE, alongside professional guidance on the implications of their test results and potential next steps in managing or monitoring their thyroid health.
The TSH Antibody Test is a specialized medical examination conducted to detect the presence of antibodies against thyroid-stimulating hormone (TSH) in the blood. These antibodies can interfere with the normal functioning of the thyroid gland, leading to conditions such as Graves' disease or Hashimoto's thyroiditis, which are autoimmune thyroid disorders. By measuring the levels of TSH antibodies, healthcare providers can diagnose and manage these conditions more effectively.
DNA Labs UAE offers this test for individuals who may be experiencing symptoms of thyroid dysfunction or for those who are being monitored for known thyroid conditions. The cost of the TSH Antibody Test at DNA Labs UAE is 2800 AED. The test is performed with precision and care, ensuring accurate results that can guide appropriate treatment plans. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experienced professionals, making it a reliable choice for your diagnostic needs.
Heparin-Induced Thrombocytopenia (HIT) is a serious immune-mediated adverse reaction to heparin, a common anticoagulant medication. This condition arises when the body generates antibodies against a complex formed between heparin and Platelet Factor 4 (PF4), leading to a paradoxical reduction in platelet count and an increased risk of thrombosis. The Anti-Platelet Factor 4-Heparin (PF4-H) IgG Quantitative Test is a specialized diagnostic assay designed to detect the presence and quantify the levels of these specific antibodies in the blood.
This test is crucial for the diagnosis and management of patients suspected of having HIT, as it helps in confirming the presence of PF4-H antibodies, thereby guiding appropriate treatment decisions. Given the potential for severe complications associated with HIT, including deep vein thrombosis, pulmonary embolism, and stroke, accurate and timely diagnosis is paramount.
In the UAE, the Anti-PF4-H IgG Quantitative Test is available at DNA Labs, a leading laboratory known for its advanced diagnostic services. The cost of the test is 2800 AED, reflecting the sophisticated nature of the assay and the expertise required to perform it. DNA Labs UAE ensures precise results, providing essential information for clinicians to manage patients who have or are at risk of developing HIT due to heparin therapy.
